您的购物车当前为空
BPR5K230 作为MER和AXL受体酪氨酸激酶的双重抑制剂,分别展示了4.1 nM和9.2 nM的IC50。该化合物还能抑制Ba/F3-MER细胞的增殖,具体IC50达到5 nM。在小鼠体内,BPR5K230展现出优秀的药代动力学属性,并在4T1、MDA-MB-231、MC38和Hepa1-6小鼠模型中显示了抗炎及抗肿瘤活性。

BPR5K230 作为MER和AXL受体酪氨酸激酶的双重抑制剂,分别展示了4.1 nM和9.2 nM的IC50。该化合物还能抑制Ba/F3-MER细胞的增殖,具体IC50达到5 nM。在小鼠体内,BPR5K230展现出优秀的药代动力学属性,并在4T1、MDA-MB-231、MC38和Hepa1-6小鼠模型中显示了抗炎及抗肿瘤活性。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 10,600 | 8-10周 | |
| 50 mg | ¥ 13,800 | 8-10周 | |
| 100 mg | ¥ 17,500 | 8-10周 |
BPR5K230 相关产品
| 产品描述 | BPR5K230 is a dual inhibitor of the receptor tyrosine kinases MER and AXL, exhibiting IC50 values of 4.1 nM and 9.2 nM, respectively. It inhibits the proliferation of Ba/F3-MER cells with an IC50 of 5 nM. BPR5K230 demonstrates favorable pharmacokinetics in mice and displays anti-inflammatory and antitumor effects in mouse models against 4T1, MDA-MB-231, MC38, and Hepa1-6. |
| 分子量 | 655.68 |
| 分子式 | C37H30FN7O4 |
| CAS No. | 3029897-97-7 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容